Alcon Launches Ilevro, NSAID for Pain, Inflammation Associated With Cataract Surgery

Alcon, Laboratories, Inc., announced the launch of Ilevro (nepafenac ophthalmic suspension), a new oncedaily treatment option for pain and inflammation associated with cataract surgery. In two double masked, randomized clinical trials, nepafenac ophthalmic suspension demonstrated superior clinical efficacy compared to ...